COST-MINIMIZATION ANALYSIS OF METHADONA OPIOID ANALGESIC FOR MEXICAN PATIENTS WITH ACUTE AND CHRONIC SECONDARY CANCER AS ROTATION OPTION IN SEVERE PAIN

被引：0
|
作者：
Soto Molina, H. [1 ]
Sanchez, K. [1 ]
Constanzo, A. [1 ]
Escobar Juarez, Y. [1 ]
Fernandez, Z. [2 ]
Melendez, C. [2 ]
机构：
[1] HS Estudios Farmacoecon, Mexico City, DF, Mexico
[2] Psicofarma SA de CV, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1700
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY70
引用
收藏
页码：A533 / A534
页数：2
相关论文
共 50 条
  • [31] PRELIMINARY COST-MINIMIZATION ANALYSIS OF CONTINUOUS VERSUS INTERMITTENT RENAL REPLACEMENT THERAPY IN INTENSIVE CARE PATIENTS EXPERIENCING ACUTE RENAL FAILURE
    Banz, K.
    Harenski, K.
    Brunner, M.
    von Czettritz, T.
    VALUE IN HEALTH, 2011, 14 (07) : A332 - A332
  • [32] Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
    Rojas, Luis
    Muniz, Sabrina
    Medina, Lidia
    Pena, Jose
    Acevedo, Francisco
    Pinto, Mauricio P.
    Sanchez, Cesar
    PLOS ONE, 2020, 15 (02):
  • [33] Decision and cost-minimization analysis of alternative diagnostic approaches in modeled patients with non-small cell lung cancer and subcarinal lymphadenopathy
    Lopez-Roman, Orlando
    Huerta, Sergio
    Siddiqui, Ali
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB359 - AB359
  • [34] COST-MINIMIZATION ANALYSIS OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK
    Schroeder, M.
    Shah, D.
    Risebrough, N.
    Ndirangu, K.
    Martin, A. A.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S235 - S235
  • [35] Pregabalin as an analgesic option for patients undergoing thoracotomy: cost analysis of pregabalin versus epidural analgesia for post-thoracotomy pain relief
    Matsutani, Noriyuki
    Yamane, Hitomi
    Suzuki, Toshiaki
    Murakami, Aya
    Haga, Yuri
    Kawamura, Masafumi
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2321 - 2330
  • [36] COST-MINIMIZATION ANALYSIS OF SMOFKABIVEN® CENTRAL FOR ADULT PATIENTS WITH IMPOSSIBLE, INSUFFICIENT OR CONTRAINDICATED ORAL OR ENTERAL NUTRITION VERSUS STANDARD ENDOVASCULAR TREATMENT IN THE MEXICAN PUBLIC HEALTHCARE SYSTEM
    Valls, M.
    Gay, J. G.
    Osorio, M.
    Fernandez, R.
    Barrera, D.
    VALUE IN HEALTH, 2018, 21 : S318 - S318
  • [37] Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer
    Graham, Christopher N.
    Hechmati, Guy
    Fakih, Marwan G.
    Knox, Hediyyih N.
    Maglinte, Gregory A.
    Hjelmgren, Jonas
    Barber, Beth
    Schwartzberg, Lee S.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (08) : 619 - 628
  • [38] COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF VENETOCLAX PLUS OBINUTUZUMAB VERSUS IBRUTINIB IN PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Vieira, F. M.
    Ribeiro, G. N.
    Brito Filho, C.
    Travassos, A.
    VALUE IN HEALTH, 2021, 24 : S39 - S39
  • [39] COST-MINIMIZATION ANALYSIS OF TRASTUZUMAB INTRAVENOUS VERSUS TRASTUZUMAB SUBCUTANEOUS FOR THE TREATMENT OF PATIENTS WITH HER2+EARLY BREAST CANCER AND METASTATIC BREAST CANCER IN GREECE
    Mylonas, C.
    Kourlaba, G.
    Fountzilas, G.
    Skroumpelos, A.
    Maniadakis, N.
    VALUE IN HEALTH, 2014, 17 (07) : A640 - A641
  • [40] Analysis of pain characteristics and prognostic factors for pain management in 152 lung cancer patients with moderate or severe chronic pain
    Wang Nanya
    Liu Yumei
    Shi Lei
    Li Wei
    PSYCHO-ONCOLOGY, 2015, 24 : 72 - 73
12345